Drug release from matrix tablets: Physiological parameters and the effect of food

Expert Opinion on Drug Delivery

Volumn 11, Issue 9, 2014, Pages 1401-1418

  Nokhodchi, Ali ^a,b   Asare Addo, Kofi ^c  

^a MEDWAY SCHOOL OF PHARMACY   (United Kingdom)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF HUDDERSFIELD   (United Kingdom)

Author keywords

Agitation rate; Biodissolution; Drug release; Effect of food; Hydrophilic matrices; Ionic strength

Indexed keywords

DILTIAZEM; FELODIPINE; HYDROCHLOROTHIAZIDE; NIFEDIPINE; PARACETAMOL; TETRACYCLINE; THEOPHYLLINE;

CONTROLLED RELEASE FORMULATION; DIFFUSION COEFFICIENT; DRUG ABSORPTION; DRUG DOSAGE FORM; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; HUMAN; HYDRODYNAMICS; IONIC STRENGTH; MATRIX TABLET; MEDICAL LITERATURE; REVIEW; TABLET DISINTEGRATION;

AGITATION RATE; BIODISSOLUTION; DRUG RELEASE; EFFECT OF FOOD; HYDROPHILIC MATRICES; IONIC STRENGTH;

ABSORPTION; ANIMALS; CHEMISTRY, PHARMACEUTICAL; DIFFUSION; DRUG DELIVERY SYSTEMS; FOOD-DRUG INTERACTIONS; HUMANS; OSMOLAR CONCENTRATION; PARTICLE SIZE; PERMEABILITY; PHARMACEUTICAL PREPARATIONS; PHARMACOPOEIAS AS TOPIC; SOLUBILITY; TABLETS;

EID: 84906316080     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2014.924498     Document Type: Review

References (174)

1. Yu ZL, Schwartz JB, Sugita ET. Theophylline controlled-release formulations: In vivo-in vitro correlations. Biopharm Drug Dispos 1996;17:259-72
2. Grundy JS, Anderson KE, Rogers JA, et al. Studies on Dissolution testing of the nifedipine gastrointestinal therapeutic system 2 improved in vitro-in vivo correlation using a two-phase dissolution test. J Control Release 1997;48:9-17
3. Soderlind E, Karlsson E, Carlsson A, et al. Simulating fasted human intestinal fluids: Understing the roles of lecithin bile acids. Mol Pharm 2010;7:1498-507
4. Mudie DM, Amidon GL, Amidon GE. Physiological parameters for oral delivery in vitro testing. Mol Pharm 2010;7:1388-405
5. Amidon GL, Lennernas H, Shah VP, et al. A theoretical basis for a biopharmaceutic drug classification - The correlation of in-vitro drug product dissolution in-vivo bioavailability. Pharm Res 1995;12:413-20
6. Asare-Addo K, Levina M, Rajabi-Siahboomi AR, et al. Study of dissolution hydrodynamic conditions versus drug release from hypermelose matrices: The influence of agitation sequence. Colloids Surf B Biointerfaces 2010;81:452-60
7. Asare-Addo K, Levina M, Rajabi-Siahboomi AR, et al. Effect of ionic strength pH of dissolution media on theophylline release from hypromellose matrix tablets - Apparatus USP III, simulated fasted fed conditions. Carbohydr Polym 2011;86:85-93
8. Asare-Addo K, Kaialy W, Levina M, et al. The influence of agitation sequence ionic strength on in-vitro drug release from hypromellose (E4 M K4 M) ER matrices - The use of the USP III apparatus. Colloids Surf B Biointerfaces 2013;104:54-60
9. Asare-Addo K, Conway BR, Larhrib H, et al. The effect of pH ionic strength of dissolution media on in-vitro release of two model drugs of different solubilities from HPMC matrices. Colloids Surf B Biointerfaces 2013;111:384-91
10. Nokhodchi A, Raja S, Patel P, et al. The role of oral controlled release matrix tablets in Drug delivery systems. Bioimpacts 2012;2:175-87
11. Ritschel WA. Targeting in the gastrointestinal-Tract - new approaches. Methods Find Exp Clin Pharmacol 1991;13:313-36
12. Bergstrom CA, Holm R, Jørgensen SA, et al. Early pharmaceutical profiling to predict oral drug absorption: Current status and unmet needs. Eur J Pharm Sci 2014;57:173-99
13. Dressman JB, Amidon GL, Reppas C, et al. Dissolution testing as a prognostic tool for oral drug absorption: Immediate release dosage forms. Pharm Res 1998;15:11-22
14. Sheng JJ, Kasim NA, Chrasekharan R, et al. Solubilization Dissolution of insoluble weak acid, ketoprofen: Effects of pH combined with surfactant. Eur J Pharm Sci 2006;29:306-14
15. Li CL, Martini LG, Ford JL, et al. The use of hypromellose in oral drug delivery. J Pharm Pharmacol 2005;57:533-46
16. Phaechamud T, Ritthidej GC. Sustained-release from layered matrix system comprising chitosan. Drug Dev Ind Pharm 2007;33:595-605
17. Efentakis M, Dressman JB. Gastric juice as a dissolution medium: Surface tension and pH. Eur J Drug Metab Pharmacokinet 1998;23:97-102
18. Pedersen BL, Müllertz A, Brøndsted H, et al. A comparison of the solubility of danazol in human and simulated gastrointestinal fluids. Pharm Res 2000;17:891-4
19. Kalantzi L, Persson E, Polentarutti B, et al. Canine intestinal contents vs simulated media for the assessment of solubility of two weak bases in the human small intestinal contents. Pharm Res 2006;23:1373-81
20. AstraZeneca, data on file. Communication with Bertil Abrahamsson och Anders Borde
21. Dressman JB, Berardi RR, Dermentzoglou LC, et al. Upper gastrointestinal (gi) ph in young, healthymen women. Pharm Res 1990;7:756-61
22. Kalantzi L, Goumas K, Kalioras V, et al. Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/ bioequivalence studies. Pharm Res 2006;23:165-76
23. Lindahl A, Ungell AL, Knutson L, et al. Characterization of fluids from the stomach proximal jejunum in men women. Pharm Res 1997;14:497-502
24. Dressman JB, Berardi RR, Dermentzoglou LC, et al. Upper gastrointestinal (gi) ph in young, healthymen women. Pharm Res 1990;7:756-61
25. Annaert P, Brouwers J, Bijnens A, et al. Ex vivo permeability experiments in excised rat intestinal tissue and in vitro solubility measurements in aspirated human intestinal fluids support agedependent oral drug absorption. Eur J Pharm Sci 2010;39:15-22
26. Perez de la Cruz Moreno M, Oth M, Deferme S, et al. Characterization of fasted-state human intestinal fluids collected from duodenum and jejunum. J Pharm Pharmacol 2006;58:1079-89
27. Benn A, Cooke WT. Intraluminal pH of duodenum and jejunum in fasting subjects with normal and abnormal gastric or pancreatic function. Scand J Gastroenterol 1971;6:313-17
28. Clarysse S, Tack J, Lammert F, et al. Postprial evolution in composition characteristics of human Duodenal fluids in Different nutritional states. J Pharm Sci 2009;98:1177-92
29. Brouwers J, Tack J, Lammert F, et al. Intraluminal drug and formulation behavior and integration in in vitro permeability estimation: A case study with amprenavir. J Pharm Sci 2006;95:372-83
30. Kossena GA, Charman WN, Wilson CG, et al. Low dose lipid formulations: Effects on gastric emptying and biliary secretion. Pharm Res 2007;24:2084-96
31. Psachoulias D, Vertzoni M, Goumas K, et al. Precipitation in and supersaturation of contents of the upper small intestine after administration of two weak bases to fasted adults. Pharm Res 2011;28:3145-58
32. Youngberg CA, Berardi RR, Howatt WF, et al. Comparison of gastrointestinal pH in cystic fibrosis and healthy subjects. Dig Dis Sci 1987;32:472-80
33. Watson BW, Meldrum SJ, Riddle HC, et al. pH profile of gut as measured by radiotelemetry capsule. Br Med J 1972;2:104-6
34. Ovesen L, Bendtsen F, Tagejensen U, et al. Intraluminal pH in the stomach, duodenum, proximal jejunum in normal subjects patients with exocrine pancreatic insufficiency. Gastroenterology 1986;90:958-62
35. Armand M, Borel P, Pasquier B, et al. Physicochemical characteristics of emulsions during fat digestion in human stomach and duodenum. Am J Physiol 1996;271:G172-83
36. Mansbach CM, Cohen RS, Leff PB. Isolation and properties of the mixed lipid micelles present in intestinal content during fat digestion in man. J Clin Invest 1975;6:781-91
37. Vertzoni M, Markopoulos C, Symillides M, et al. Luminal lipid phases after administration of a triglyceride solution of danazol in the fed state and their contribution to the flux of Danazol across Caco-2 cell monolayers. Mol Pharm 2012;9:1189-98
38. Persson EM, Gustafsson AS, Carlsson AS, et al. The effects of food on the dissolution of poorly soluble drugs in human and in model small intestinal fluids. Pharm Res 2005;22:2141-51
39. Sheng JJ, McNanara DP, Amidon GL. Toward an in vivo dissolution methodology: A comparison of phosphate bicarbonate buffers. Mol Pharm 2009;6:29-39
40. Fadda HM, Sousa T, Carlsson AS, et al. Drug solubility in luminal fluids from different regions of the small large intestine of humans. Mol Pharm 2010;7:1527-32
41. Cummings JH, Pomare EW, Branch WJ, et al. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 1987;28:1221-7
42. Cummings JH. Colonic absorption: The importance of short chain fatty acids in man. Scand J Gastroenterol Suppl 1984;93:89-99
43. Ladas SD, Isaacs PE, Murphy GM, et al. Fasting and postprandial ileal function in adapted ileostomates and normal subjects. Gut 1986;27:906-12
44. Kanaghinis T, Lubran M, Coghill NF. The composition of ileostomy fluid. Gut 1963;4:322-38
45. Clarysse S, Psachoulias D, Brouwers J, et al. Postprial changes in solubilizing capacity of human intestinal fluids for BCS class II drugs. Pharm Res 2009;26:1456-66
46. Pedersen PB, Vilmannb P, Bar-Shalom D, et al. Characterization of fasted human gastric fluid for relevant rheological parameters and gastric lipase activities. Eur J Pharm Biopharm 2013;85:958-65
47. Jantratid E, Janssen N, Reppas C, et al. Dissolution media simulating conditions in the proximal human gastrointestinal tract: An update. Pharm Res 2008;25:1663-76
48. Dikeman CL, Fahey GC Jr. Viscosity as related to dietary fiber: A review. Crit Rev Food Sci Nutr 2006;46:649-63
49. Marciani L, Gowl PA, Spiller RC, et al. Gastric response to increased meal viscosity assessed by echo-planar magnetic resonance imaging in humans. J Nutr 2000;130:122-7
50. Malkki Y. Physical properties of dietary fiber as keys to physiological functions. Cereal Foods World 2001;46:196-9
51. Abrahamsson B, Pal A, Sjoberg M, et al. A novel in vitro and numerical analysis of shear-induced drug release from extended-release tablets in the fed stomach. Pharm Res 2005;22:1215-26
52. Kwiatek MA, Menne D, Steingoetter A, et al. Effect of meal volume calorie load on postprial gastric function emptying: Studies under physiological conditions by combined fiber-optic pressure measurement and MRI. Am J Physiol Gastrointest Liver Physiol 2009;297:G894-901
53. DeSesso JM, Jacobson CF. Anatomical physiological parameters affecting gastrointestinal absorption in humans and rats. Food Chem Toxicol 2001;39:209-28
54. Dressman JB. Comparison of canine human gastrointestinal physiology. Pharm Res 1986;3:123-31
55. McConnell EL, Fadda HM, Basit AW. Gut instincts: Explorations in intestinal physiology drug delivery. Int J Pharm 2008;364:213-26
56. Dahan AS, Amidon GL. Gastrointestinal dissolution and absorption of class II drugs. In: Drug bioavailability: Estimation of solubility, permeability, absorption and bioavailability. Volume 40 2nd edition. Wiley-VCH Verlag GmbH &Co., KgaA, Germany; 2009. p. 33-51
57. Lim CL, Byrne C, Lee JK. Human thermoregulation and measurement of body temperature in exercise and clinical settings. Ann Acad Med Singapore 2008;37:347-57
58. Weitschies W, Kosch O, Monnikes H, et al. Magnetic marker monitoring: An application of biomagnetic measurement instrumentation principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms. Adv Drug Deliv Rev 2005;57:1210-22
59. McConnell EL, Fadda HM, Basit AW. Gut instincts: Explorations in intestinal physiology drug delivery. Int J Pharm 2008;364:213-26
60. Coupe AJ, Davis SS, Wilding IR. Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects. Pharm Res 1991;8:360-4
61. Yu LX, Amidon GL. Characterization of small intestinal transit time distribution in humans. Int J Pharm 1998;171:157-63
62. Arhan P, Devroede G, Jehannin B, et al. Segmental colonic transit-Time. Dis Colon Rectum 1981;24:625-9
63. Bouchoucha M, Devroede G, Faye A, et al. Importance of colonic transit evaluation in the management of fecal incontinence. Int J Colorectal Dis 2002;17:412-17
64. Wagener S, Shankar KR, Turnock RR, et al. Colonic transit time - what is normal?. J Pediatr Surg 2004;39:166-9
65. Culen M, Rezacova A, Jampilek J, et al. Designing a dynamic dissolution method: A review of instrumental options corresponding physiology of stomach small intestine. J Pharm Sci 2013;102:2995-3017
66. Klein S. The use of biorelevant dissolution media to forecast the in vivo performance of a drug. AAPS J 2010;12:397-406
67. Gray VA, Dressman JB. Change of pH requirements for simulated intestinal fluid TS. Pharmacopeial Forum 1996;22:1943-5
68. Galia E, Nicolaides E, Horter D, et al. Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs. Pharm Res 1998;15:698-705
69. Vertzoni M, Dressman JB, Butler J, et al. Simulation of fasting gastric conditions its importance for the in vivo dissolution of lipophilic compounds. Eur J Pharm Biopharm 2005;60:413-17
70. Vertzoni M, Pastelli E, Psachoulias D, et al. Estimation of intragastric solubility of drugs: In what medium?. Pharm Res 2007;24:909-17
71. Erceg M, Vertzoni M, Cerić H, et al. In vitro vs canine data for assessing early exposure of doxazosin base and its mesylate salt. Eur J Pharm Biopharm 2012;80:402-9
72. Hofmann AF, Small DM. Detergent properties of bile salts: Correlation with physiological function. Annu Rev Med 1967;18:333-76
73. Redinger RN, Small DM. Bile composition, bile-salt metabolism gallstones. Arch Intern Med 1972;130:618-30
74. Carey MC, Small DM. Micelle formation by bile salts: Physical-chemical and thermodynamic considerations. Arch Intern Med 1972;130:506-27
75. Klein S, Butler J, Hempenstall JM, et al. Media to simulate the postprandial stomach I. Matching the physicochemical characteristics of standard breakfasts. J Pharm Pharmacol 2004;56:605-10
76. Greenwood D. Small intestinal pH and buffer capacity: Implications for dissolution of ionizable compounds. Doctoral thesis University of Michigan, Ann Arbor; 1994
77. Fagerberg JH, Tsinman O, Sun N, et al. Dissolution rate apparent solubility of poorly soluble drugs in biorelevant dissolution media. Mol Pharm 2010;7:1419-30
78. Grove M, Pedersen GP, Nielsen JL, et al. Bioavailability of seocalcitol I: Relating solubility in biorelevant media with oral bioavailability in rats - effect of medium and long chain triglycerides. J Pharm Sci 2005;94:1830-8
79. Nielsen FS, Mullertz A. Development of in vitro methods for the evaluation of formulation performance. Bull Tech Gattefossé 2005;98:75-87
80. Kleberg K, Jacobsen F, Fatouros DG, et al. Biorelevant media simulating fed state intestinal fluids: Colloid phase characterization and impact on solubilization capacity. J Pharm Sci 2010;99:3522-32
81. Jung H, Milan RC, Girard ME, et al. Bioequivalence study of carbamazepine tablets: In vitro-in vivo correlation. Int J Pharm 1997;152:37-44
82. Jantratid E, De Maio V, Ronda E, et al. Application of biorelevant dissolution tests to the prediction of in vivo performance of diclofenac sodium from an oral modified-release pellet dosage form. Eur J Pharm Sci 2009;37:434-41
83. Jonkman JHG. Food interactions with sustained-release theophylline preparations - A review. Clin Pharmacokinet 1989;16:162-79
84. Florence AT, Jani PU. Novel oral-drug formulations - Their potential in modulating adverse-effects. Drug Saf 1994;10:233-66
85. Welling PG. Effects of food on Drug absorption. Annu Rev Nutr 1996;16:383-415
86. Phuapradit W, Bolton S. The influence of tablet density on the human oral absorption of sustained-release acetaminophen matrix tablets. Drug Dev Ind Pharm 1991;17:1097-107
87. Abrahamsson B, Roos K, Sjogren J. Investigation of prandial effects on hydrophilic matrix tablets. Drug Dev Ind Pharm 1999;25:765-71
88. Fleisher D, Li C, Zhou Y, et al. Drug, meal and formulation interactions influencing drug absorption after oral administration. Clin Pharmacokinet 1999;36:233-54
89. Yu LX, Straughn AB, Faustino PJ, et al. The effect of food on the relative bioavailability of rapidly dissolving immediate-release solid oral products containing highly soluble drugs. Mol Pharm 2004;1:357-62
90. Lentz KA. Current methods for predicting human food effect. AAPS J 2008;10:282-8
91. Wilson CG, Washington N. The stomach: Its role in Drug delivery. In: Rubinstein MH, editor. Physiological Pharmaceutics the stomach: Its role in Drug delivery. Ellis Horwood Ltd; Chichester: 1989. p. 47-68
92. Abrahamsson B, Albery T, Eriksson A, et al. Food effects on tablet disintegration. Eur J Pharm Sci 2004;22:165-72
93. Abrahamsson B, Alpsten M, Hugosson M, et al. Absorption, gastrointestinal transit, tablet erosion of felodipine extended-release (ER) tablets. Pharm Res 1993;10:709-14
94. Abrahamsson B, Alpsten M, Bake B, et al. Drug absorption from nifedipine hydrophilic matrix extended-release (ER) tablet-comparison with an osmotic pump tablet effect of food. J Control Release 1998;52:301-10
95. Charman WN, Porter CJH, Mithani S, et al. Physicochemical physiological mechanisms for the effects of food on Drug absorption: The role of lipids pH. J Pharm Sci 1997;86:269-82
96. Waltersack IE, Devries JX, Nickel B, et al. The influence of different formula diets different pharmaceutical formulations on the systemic availability of paracetamol, gallbladder size, plasma-glucose. Int J Clin Pharmacol Ther Toxicol 1989;27:544-50
97. Sunesen VH, Vedelsdal R, Kristensen HG, et al. Effect of liquid volume food intake on the absolute bioavailability of danazol, a poorly soluble drug. Eur J Pharm Sci 2005;24:297-303
98. Leyden JJ. Absorption of minocycline hydrochloride tetracycline hydrochloride - effect of food, milk, iron. J Am Acad Dermatol 1985;12:308-12
99. Klein S. Predicting food effects on Drug release from extended-release oral dosage forms containing a narrow therapeutic index drug. Dissol Technol 2009;16:28-40
100. Hendeles L, Weinberger M, Milavetz G, et al. Food-induced dose-dumping from a once-A-day theophylline product as a cause of theophylline toxicity. Chest 1985;87:758-65
101. Steffensen G, Pedersen S. Food induced changes in theophylline absorption from a once-A-day theophylline product. Br J Clin Pharmacol 1986;22:571-7
102. Jonkman JHG. Food interactions with once-A-day theophylline preparations - A review. Chronobiol Int 1987;4:449-58
103. Karim A, Burns T, Wearley L, et al. Food-induced changes in theophylline absorption from controlled-release formulations 1 substantial increased decreased absorption with uniphyl tablets theo-dur sprinkle. Clin Pharmacol Ther 1985;38:77-83
104. Marasanapalle VP, Crison JR, Ma J, et al. Investigation of some factors contributing to negative food effects. Biopharm Drug Dispos 2009;30:71-80
105. Nokhodchi A, Norouzi-Sani S, Siahi-Shadbad MR, et al. The effect of various surfactants on the release rate of propranolol hydrochloride from hydroxypropylmethylcellulose (HPMC)-eudragit matrices. Eur J Pharm Biopharm 2002;54:349-56
106. Ford JL, Rubinstein MH, McCaul F, et al. Importance of drug type, tablet shape added diluents on Drug release kinetics from hydroxypropylmethylcellulose matrix tablets. Int J Pharm 1987;40:223-34
107. Kim H, Fassihi R. Application of binary polymer system in Drug release rate modulation 2 influence of formulation variables hydrodynamic conditions on release kinetics. J Pharm Sci 1997;86:323-8
108. Gupta VK, Hariharan M, Wheatley TA, et al. Controlled-release tablets from carrageenans: Effect of formulation, storage dissolution factors. Eur J Pharm Biopharm 2001;51:241-8
109. Bettini R, Catellani PL, Santi P, et al. Translocation of drug particles in HPMC matrix gel layer: Effect of drug solubility influence on release rate. J Control Release 2001;70:383-91
110. Heng PWS, Chan LW, Easterbrook MG. Investigation of the influence of mean HPMC particle size number of polymer particles on the release of aspirin from swellable hydrophilic matrix tablets. J Control Release 2001;76:39-49
111. Kaialy W, Emami P, Asare-Addo K, et al. Psyllium: A promising polymer for sustained release formulations in combination with HPMC polymers. Pharm Dev Technol 2014;19:269-77
112. Shojaee S, Asare-Addo K, Kaialy W, et al. An investigation into the stabilization of diltiazem HCl release from matrices made from aged polyox powders. AAPS PharmSciTech 2013;14:1190-8
113. Siahi-Shadbad M, Asare-Addo K, Azizian K, et al. Release behaviour of propranolol HCl from hydrophilic matrix tablets containing psyllium powder in combination with hydrophilic polymers. AAPS PharmSciTech 2011;12:1176-82
114. Bonferoni MC, Rossi S, Ferrari F, et al. A study of three hydroxypropylmethyl cellulose substitution types: Effect of particle size shape on hydrophilic matrix performances. STP Pharma Sci 1996;6:277-84
115. Velasco MV, Ford JL, Rowe P, et al. Influence of drug: Hydroxypropylmethylcellulose ratio, drug polymer particle size compression force on the release of diclofenac sodium from HPMC tablets. J Control Release 1999;57:75-85
116. Nokhodchi A, Rubinstein MH, Ford JL. The effects of viscosity grade hydroxypropylmethylcellulose (HPMC) on its compaction properties. J Pharm Pharmacol 1994;46:1075
117. Nokhodchi A, Rubinstein MH, Ford JL. The effect of particle size viscosity grade on the compaction properties of hydroxypropylmethylcellulose 2208. Int J Pharm 1995;126:189-97
118. Aulton ME. Pharmaceutics: The design and manufacture of medicine. Churchill Livingstone; Philadelphia: 2007
119. Noyes AA, Whitney WR. The rate of solution of solid substances in their own solutions. J Am Chem Soc 1897;19:930-4
120. Fassihi AR, Munday DL. Dissolution of theophylline from film-coated slow release mini-Tablets in various dissolution media. J Pharm Pharmacol 1989;41:369-72
121. Williams RL, Upton RA, Ball L, et al. Development of a new controlled-release formulation of chlorpheniramine maleate using invitro invivo correlations. J Pharm Sci 1991;80:22-5
122. Fassihi RA, Ritschel WA. Multiple-layer, direct-compression, controlled-release system - in-vitro and in-vivo evaluation. J Pharm Sci 1993;82:750-4
123. Gordon MS, Rudraraju VS, Dani K, et al. Effect of the mode of super disintegrant incorporation on Dissolution in wet granulated tablets. J Pharm Sci 1993;82:220-6
124. Naylor LJ, Bakatselou V, Dressman JB. Comparison of the mechanism of dissolution of hydrocortisone in simple and mixed micelle systems. Pharm Res 1993;10:865-70
125. Omelczuk MO, Mcginity JW. The influence of thermal-Treatment on the physical-mechanical and dissolution properties of tablets containing poly(dllactic acid). Pharm Res 1993;10:542-8
126. Wang Z, Horikawa T, Hirayama F, et al. Design and in-vitro evaluation of a modified-release oral dosage form of nifedipine by hybridization of hydroxypropyl-beta-cyclodextrin and hydroxypropylcellulose. J Pharm Pharmacol 1993;45:942-6
127. de Villiers MM, Van Der Watt JG. The measurement of mixture homogeneity and dissolution to predict the degree of drug agglomerate breakdown achieved through powder mixing. Pharm Res 1994;11:1557-61
128. Munday DL, Fassihi AR. In-vitro in-vivo correlation studies on a novel controlledrelease theophylline delivery system and on theo-dur tablets. Int J Pharm 1995;118:251-5
129. Rekhi GS, Jambhekar SS. Bioavailability and in-vitro/in-vivo correlation for propranolol hydrochloride extendedrelease bead products prepared using aqueous polymeric dispersions. J Pharm Pharmacol 1996;48:1276-84
130. Gouldson MP, Deasy PB. Use of cellulose ether containing excipients with microcrystalline cellulose for the production of pellets containing metformin hydrochloride by the process of extrusion-spheronization. J Microencapsul 1997;14:137-53
131. Diakidou A, Vertzoni M, Abrahamsson B, et al. Simulation of gastric lipolysis prediction of felodipine release from a matrix tablet in the fed stomach. Eur J Pharm Sci 2009;37:133-40
132. Pal A, Indireshkumar K, Schwizer W, et al. Gastric flow mixing studied using computer simulation. Proc Biol Sci 2004;271:2587-94
133. Pillay V, Fassihi AR. Evaluation comparison of dissolution Data derived from different modified release dosage forms: An alternative method. J Control Release 1998;55:45-55
134. Khoury N, Mauger JW, Howard S. Dissolution rate studies from a stationary disk rotating fluid system. Pharm Res 1988;5:495-500
135. Bocanegra LM, Morris GJ, Jurewicz JT, Mauger JW. Fluid particle laser doppler velocity-measurements mass-Transfer predictions for the USP paddle method dissolution apparatus. Drug Dev Ind Pharm 1990;16:1441-64
136. Carino SR, Sperry DC, Hawley M. Relative bioavailability estimation of carbamazepine crystal forms using an artificial stomach-duodenum model. J Pharm Sci 2006;95:116-25
137. Cohen JL, Hubert BB, Leeson LJ, et al. The development of USP dissolution Drug release stards. Pharm Res 1990;7:983-7
138. Klein S, Rudolph MW, Skalsky B, et al. Use of the BioDis to generate a physiologically relevant IVIVC. J Control Release 2008;130:216-19
139. Fotaki N, Aivaliotis A, Butler J, et al. A comparative study of different release apparatus in generating in vitro-in vivo correlations for extended release formulations. Eur J Pharm Biopharm 2009;73:115-20
140. McAllister M. Dynamic dissolution: A step closer to predictive dissolution testing?. Mol Pharm 2010;7:1374-87
141. Diebold SM. Physiological parameters relevant to dissolution testing: Hydrodynamic considerations. In: Dressman JB, Kramer J, editors. Pharmaceutical dissolution. Taylor &Francis; London, U.K: 2005. p. 127-91
142. Fotaki N, Vertzoni M. Biorelevant dissolution methods and their applications in in vitro-in vivo correlations for oral formulations. Open Drug Deliv J 2010;4:2-13
143. Carino SR, Sperry DC, Hawley M. Relative bioavailability estimation of carbamazepine crystal forms using an artificial stomach-duodenum model. J Pharm Sci 2006;95:116-25
144. Gao Y, Carr RA, Spence JK, et al. A pH-dilution method for estimation of biorelevant drug solubility along the gastrointestinal tract: Application to physiologically based pharmacokinetic modeling. Mol Pharm 2010;7:1516-26
145. Gu CH, Rao D, Ghi RB, et al. Using a novel multicompartment dissolution system to predict the effect of gastric pH on the oral absorption of weak bases with poor intrinsic solubility. J Pharm Sci 2005;94:199-208
146. Garbacz G, Wedemeyer RS, Nagel S, et al. Irregular absorption profiles observed from diclofenac extended release tabletscan be predicted using a dissolution test apparatus that mimics in vivo physical stresses. Eur J Pharm Biopharm 2008;70:421-8
147. Garbacz G, Golke B, Wedemeyer RS, et al. Comparison of dissolution profiles obtained from nifedipine extended release once a day products using different dissolution test apparatuses. Eur J Pharm Sci 2009;38:147-55
148. Kostewicz ES, Wunderlich M, Brauns U, et al. Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine. J Pharm Pharmacol 2004;56:43-51
149. Psachoulias D, Vertzoni M, Butler J, et al. An in vitro methodology for forecasting luminal concentrations and precipitation of highly permeable lipophilic weak bases in the fasted upper small intestine. Pharm Res 2012;29:3486-98
150. Vardakou M, Mercuri A, Barker SA, et al. Achieving antral grinding forces in biorelevant in vitro models: Comparing the USP dissolution apparatus II the dynamic gastric model with human in vivo data. AAPS PharmSciTech 2011;12:620-6
151. Vardakou M, Mercuri A, Naylor TA, et al. Predicting the human in vivo performance of different oral capsule shell types using a novel in vitro dynamic gastric model. Int J Pharm 2011;419:192-9
152. Mercuri A, Passalacqua A, Wickham MSJ, et al. The effect of composition gastric conditions on the self-emulsification process of ibuprofen loaded self-emulsifying drug delivery systems: A microscopic dynamic gastric model study. Pharm Res 2011;28:1540-51
153. Lo CA, Pitino I, Mandalari G, et al. Survival of probiotic lactobacilli in the upper gastrointestinal tract using an in vitro gastric model of digestion. Food Microbiol 2011;28:1359-66
154. Pitino I, Randazzo CL, Mandalari G, et al. Survival of Lactobacillus rhamnosus strains in the upper gastrointestinal tract. Food Microbiol 2010;27:1121-7
155. Wickham M, Faulks R, Mills C. In vitro digestion methods for assessing the effect of food structure on allergen breakdown. Mol Nutr Food Res 2009;53:952-8
156. Blanquet S, Zeijdner E, Beyssac E, et al. A dynamic artificial gastrointestinal system for studying the behavior of orally administered drug dosage forms under various physiological conditions. Pharm Res 2004;21:585-91
157. Souliman S, Beyssac E, Cardot JM, et al. Investigation of the biopharmaceutical behavior of theophylline hydrophilic matrix tablets using USP methods an artificial digestive system. Drug Dev Ind Pharm 2007;33:475-83
158. Souliman S, Blanquet S, Beysac E, et al. A level A in vitro/in vivo correlation in fasted fed states using different methods: Applied to solid immediate release oral dosage form. Eur J Pharm Sci 2006;27:72-9
159. Naylor TA, Connolly PC, Martini LG, et al. Use of a gastro-intestinal model GastroplusTM for the prediction of in vivo performance. Appl Ther Res 2006;6:15-19
160. Minekus M, Marteau P, Havenaar R, et al. A multicompartmental dynamic computer-controlled model simulating the stomach and small intestine. ATLA 1995;23:197-209
161. Ronald SH, Gazzaniga A, Sangalli ME, et al. Drug/polymer matrix swelling and dissolution. Pharm Res 1988;5:488-94
162. Colombo P, Bettini R, Massimo G, et al. Drug diffusion front movement is important in Drug release control from swellable matrix tablets. J Pharm Sci 1995;84:991-7
163. Colombo P, Bettini R, Santi P, et al. Analysis of the swelling and release mechanisms from drug delivery systems with emphasis on Drug solubility and water transport. J Control Release 1996;39:231-7
164. Talukdar MM, Kinget R. Swelling and drug release behaviour of xanthan gum matrix tablets. Int J Pharm 1995;120:63-72
165. Hodsdon AC, Mitchell JR, Davies MC, et al. Structure behavior in hydrophilic matrix sustained-release dosage forms 3 the influence of ph on the sustainedrelease performance internal gel structure of sodium alginate matrices. J Control Release 1995;33:143-52
166. Mu X, Tobyn MJ, Staniforth JN. Influence of physiological variables on the in vitro drug-release behavior of a polysaccharide matrix controlled-release system. Drug Dev Ind Pharm 2003;29:19-29
167. Johnson JL, Holinej J, Williams MD. Influence of ionic strength on matrix integrity drug release from hydroxypropyl cellulose compacts. Int J Pharm 1993;90:151-9
168. Bonferoni MC, Rossi S, Ferrari F, et al. Influence of medium on Dissolutionerosion behavior of na carboxymethylcellulose on viscoelastic properties of gels. Int J Pharm 1995;117:41-8
169. Mikac U, Sepe A, Kristl J, et al. A new approach combining different MRI methods to provide detailed view on swelling dynamics of xanthan tablets influencing drug release at different pH and ionic strength. J Control Release 2010;145:247-56
170. Kavanagh N, Corrigan OI. Swelling erosion properties of hydroxypropylmethylcellulose (hypromellose) matrices - influence of agitation rate dissolution medium composition. Int J Pharm 2004;279:141-52
171. Schott H. Colloidal dispersions. In: Gennaro AR, editor. Remington: The science practice of pharmacy Philadelphia College of Pharmacy Science. 19th edition. Mack Publishing Co., Easton, PA; 1995. p. 252-77
172. Sheng JJ, Kasim NA, Chrasekharan R, et al. Solubilization Dissolution of insoluble weak acid, ketoprofen: Effects of pH combined with surfactant. Eur J Pharm Sci 2006;29:306-14
173. Avdeef A, Barrett DA, Shaw PN, et al. Octanol-, chloroform-, and propylene glycol dipelargonat-water partitioning of morphine-6-glucuronide and other related opiates. J Med Chem 1996;39:4377-81
174. Avdeef A. Absorption and drug development: Solubility, permeability, and charge state. John Wiley &Son, New Jersey; 2003.